Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Gandjour A. Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results. PLoS One 2020;15:e0236543. [PMID: 33006987 PMCID: PMC7531817 DOI: 10.1371/journal.pone.0236543] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2018] [Accepted: 07/08/2020] [Indexed: 01/03/2023] Open

For:	Gandjour A. Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results. PLoS One 2020;15:e0236543. [PMID: 33006987 PMCID: PMC7531817 DOI: 10.1371/journal.pone.0236543] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2018] [Accepted: 07/08/2020] [Indexed: 01/03/2023] Open

Number

Cited by Other Article(s)

Mühlbacher AC, Sadler A. Comment on the paper "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results". PLoS One 2021;16:e0245480. [PMID: 33600462 PMCID: PMC7891755 DOI: 10.1371/journal.pone.0245480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2020] [Accepted: 12/22/2020] [Indexed: 11/18/2022] Open